Risky stimulants turn up – again – in weight loss and workout supplements

Posted 13 November 2017

This article, by Rebecca Robbins and published in StatNews, reports on “[T]he ingredients, apparently new, were popping up on the labels of dietary supplements marketed for weight loss and workouts. Sometimes the label said DMHA. Sometimes, Aconitum kusnezoffii. Or other, even harder-to-parse names”.

“Dr. Pieter Cohen, the Harvard internist and noted supplement detective, took the case. He and his collaborators purchased and analyzed six supplements marked as containing one of the mystery ingredients. They expected that, however they were listed, all the ingredients would turn out to be a stimulant known as octodrine, which the Food and Drug Administration approved decades ago, in inhaled form, as a treatment for bronchitis, laryngitis, and other conditions.”

Continue reading at StatNews

Read the rest

MHRA launch ‘DMAA Week of Action’

Posted 01 February 2017

From: Medicines and Healthcare products Regulatory Agency (MHRA)

First published: 30 January 2017

MHRA has launched a ‘Week of Action’ to improve awareness of unlicensed medicines containing the potentially dangerous ingredient DMAA.

The Medicines and Healthcare products Regulatory Agency has launched a ‘Week of Action’ between 30th January and 5th February aimed at improving awareness of unlicensed medicines containing the potentially dangerous ingredient DMAA.

The week of action aims to improve public awareness and encourages consumers of sports supplements to check to see if their products contain DMAA or any alternative names of the potentially dangerous ingredient. It includes an animated social media campaign, health & fitness bloggers sharing their stories and a video with Dr Chris Jones and weightlifters.

Read the rest

Oregon expands lawsuit against GNC

Posted 26 September 2016

The Oregon Attorney General has expanded its lawsuit that charged General Nutrition Corporation (GNC) with selling dietary supplements that contain illegal ingredients.

The original complaint, filed in October 2015, concerned picamilon and BMPEA.

Picamilon is a synthetic chemical that is not approved in the United States, but is used as a prescription drug in some countries to treat neurological conditions. BMPEA is a powerful stimulant and amphetamine-like substance that is sometimes sold as a weight-loss or performance-enhancing supplement.

The original complaint alleges that GNC violated the Oregon Unlawful Trade Practices Act (UTPA) by misrepresenting the products as lawful when they are not legal to sell as dietary supplements in the United States.

Read the rest